๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
* The study is evaluating the safety and tolerability of Nivolumab (BMS-936...
Status
Completed
Location
Ucla
Start Date
2011-12-16
Trial ID
NCT01454102
Treatments Being Tested
The purpose of this study is to determine a safe dose of LY573636 (tasisula...
Status
Terminated
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2008-07
Trial ID
NCT01284335
Treatments Being Tested
Stage IIIA NSCLC represents a relatively heterogeneous group of pts with ip...
Status
Unknown
Location
Guangdong General Hospital
Start Date
2011-12-05
Trial ID
NCT01407822
Treatments Being Tested
This 2 arm study will compare the efficacy and safety of sequential treatme...
Status
Completed
Location
Multiple Locations
Start Date
2009-04
Trial ID
NCT00883779
Treatments Being Tested
Numerous evidences verified that erlotinib could dramatically improve the P...
Status
Unknown
Location
Hunan Province Tumor Hospital
Start Date
2014-07-01
Trial ID
NCT02098954
Treatments Being Tested
This study will aims to determine the maximum tolerated dose of CGC-11047 w...
Status
Completed
Location
Rocky Mountain Cancer Centre
Start Date
2006-05
Trial ID
NCT00705874
This study will compare the efficacy and safety of molecularly-guided thera...
Status
Completed
Location
Blacktown Hospital
Start Date
2018-07-10
Trial ID
NCT03498521
This was an open-label, multicenter, single-arm, Phase II trial of bevacizu...
Status
Completed
Location
Multiple Locations
Start Date
2006-03
Trial ID
NCT00312728
Treatments Being Tested
The purpose of this study is to determine the response rate of gemcitabine,...
Status
Completed
Location
Dong-A University Hospital
Start Date
2009-06
Trial ID
NCT00922896
Treatments Being Tested
This ALCHEMIST trial studies genetic testing in screening patients with sta...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-09-26
Trial ID
NCT02194738
Treatments Being Tested